Eris Lifesciences - Acquisition To Expand Diabetes Offerings, Add Oncology Products: Motilal Oswal

Execution remains key over next 15-18 months

<div class="paragraphs"><p>Close up tablets arranged for photograph. (Source: pxhere)</p></div>
Close up tablets arranged for photograph. (Source: pxhere)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More